Intestinal Peptide Glicentin Enhances Insulin Secretion and Reduces Feeding in Mice
A new study reveals that the protease-resistant gut peptide glicentin improves glucose tolerance, reduces food intake, and supports beta-cell function ...
A new study reveals that the protease-resistant gut peptide glicentin improves glucose tolerance, reduces food intake, and supports beta-cell function ...
An engineered probiotic expressing GLP-1 reduced body weight and alleviated gastrointestinal adverse responses in high-fat diet-fed obese mice.
A perspective in Frontiers in Endocrinology proposes the Metabo Quit hypothesis to test whether substituting D-allulose can moderate postprandial nutrient-responsive ...
Researchers are investigating natural compounds that influence incretin pathways as a potential therapeutic strategy for managing osteoporosis and osteoarthritis.
A randomized crossover trial found that consuming leafy vegetables with canola oil before a high-glycemic meal blunted postprandial glucose and ...
Refrigerated storage and compact matrix architecture reduce rapidly digestible starch and stimulate higher intestinal hormone secretion in nixtamalized maize foods.
A review in Science evaluates how obesity and diabetes drugs influence brain function and whether they could help preserve cognitive ...
A new debate article argues that GLP-1 adoption in wealthy nations may drive Big Food to intensify marketing and sales ...
Prophylactic administration of Pediococcus pentosaceus LI05 attenuated colitis symptoms, reduced intestinal fibrosis, and increased GLP-1 levels in mice with chronic ...
A nationwide cohort study in Israel found that combining SGLT2 inhibitors with GLP-1 receptor agonists was associated with reduced risks ...
A unimolecular conjugate combining incretin co-agonism with pan-PPAR activation reduced body weight and improved glycemic control in obese mice without ...
A matched nested case-control study reveals that while absolute GLP-1 levels are similar in women with gestational diabetes and normal ...
A study in Fluids and Barriers of the CNS finds that the dual GLP-1/GIP agonist DA3-CH reduces oxidative stress and ...
In a retrospective cohort study, GLP-1 receptor agonist use was associated with a 48 percent lower hazard of post-stroke dementia ...
A retrospective study of over 46,000 propensity-matched women with diabetes and hypertension found GLP-1 receptor agonist use was associated with ...
A 24-week controlled study found that a standardized eight-plant botanical formulation significantly reduced HbA1c, insulin resistance and inflammation in adults ...
Liraglutide reduced proteinuria and kidney injury in lupus-prone mice through anti-inflammatory, antioxidant, and ferroptosis-related mechanisms, with cAMP signaling implicated.
A new review maps how estradiol synergizes with insulin, leptin, adiponectin, GLP-1 and ghrelin to coordinate appetite and glucose control ...
A retrospective matched study of 16,792 patients with type 2 diabetes found GLP-1 receptor agonist use before necrotizing soft tissue ...
Current evidence shows that while GLP-1 receptor agonists increase retained gastric contents, they have not been linked to a corresponding ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.